Seres Therapeutics, Inc. (MCRB)
NASDAQ · Healthcare
Seres Therapeutics, Inc. Shareholder Equity 2015–2025
Seres Therapeutics, Inc. annual shareholder equity history from 2015 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Seres Therapeutics, Inc. shareholder equity as of December 31, 2025: 44.2M, a 220.79% increase year-over-year.
- Seres Therapeutics, Inc. shareholder equity for 2025 were 44.2M, a 220.79% increase from 2024.
- Seres Therapeutics, Inc. shareholder equity for 2024 were 13.8M, a 130.73% decrease from 2023.
- Seres Therapeutics, Inc. shareholder equity for 2023 were -44.9M, a 515.99% decrease from 2022.
- Seres Therapeutics, Inc. shareholder equity for 2022 were 10.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Seres Therapeutics, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $44 |
| 2024 | $14 |
| 2023 | $-45 |
| 2022 | $11 |
| 2021 | $132 |
| 2020 | $175 |
| 2019 | $-48 |
| 2018 | $-48 |
| 2017 | $61 |
| 2016 | $133 |
| 2015 | $205 |
Seres Therapeutics, Inc. Shareholder Equity — FAQ
Seres Therapeutics, Inc. (MCRB) shareholder equity over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MCRB's shareholder equity history?
The chart and table above show Seres Therapeutics, Inc.'s shareholder equity by year and by quarter, including the growth rate.